{"id":"W3156170207","doi":"10.1016/j.ctarc.2021.100378","title":"RELAY, ramucirumab plus erlotinib versus placebo plus erlotinib in patients with untreated, EGFR-mutated, metastatic non-small cell lung cancer: Europe/United States subset analysis","year":2021,"lang":"en","type":"article","venue":"Cancer Treatment and Research Communications","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Eli Lilly and Company","keywords":"Erlotinib; Ramucirumab; Internal medicine; Medicine; Placebo; Population; Oncology; Lung cancer; Subgroup analysis; Gastroenterology; Cancer; Epidermal growth factor receptor; Pathology; Confidence interval","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002966253,0.0004364486,0.0008017403,0.001029586,0.0007776949,0.0001668909,0.0003714424,0.0001008193,0.0002476114],"category_scores_gemma":[0.00006837204,0.000327414,0.0001512028,0.004814568,0.0004121607,0.0001707642,0.0002675245,0.0005507273,0.0000161768],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00303536,"about_ca_system_score_gemma":0.002758272,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.01952549,"about_ca_topic_score_gemma":0.02983302,"domain_scores_codex":[0.9967067,0.0006772063,0.0005398436,0.0007361147,0.000554487,0.0007856169],"domain_scores_gemma":[0.9953591,0.0008606362,0.0001841642,0.00170426,0.001448478,0.0004433872],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01139767,0.005817514,0.9037652,0.0004904563,0.02105265,0.0004244786,0.02137161,0.02555294,0.00006184813,0.0001782117,0.002122553,0.007764858],"study_design_scores_gemma":[0.2801751,0.006768083,0.5211509,0.002112462,0.04083159,0.00002458445,0.01964691,0.08563576,0.001531258,0.00003856829,0.03996219,0.002122565],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9726945,0.01558183,0.00003693757,0.004350194,0.00008788287,0.003467653,0.001150596,0.00008213746,0.002548334],"genre_scores_gemma":[0.9350438,0.04428303,0.001394935,0.0001140666,0.00003207661,0.002954257,0.01055301,0.00009225395,0.005532551],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3826143,"threshold_uncertainty_score":0.9999178,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06056040138403024,"score_gpt":0.4003621795605682,"score_spread":0.3398017781765379,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}